134 related articles for article (PubMed ID: 38840203)
1. The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness.
Huang R; He Y; Zhang C; Luo Y; Chen C; Tan N; Ren Y; Xu K; Yuan L; Yang J
Virol J; 2024 Jun; 21(1):128. PubMed ID: 38840203
[TBL] [Abstract][Full Text] [Related]
2. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
Lee E; Lobigs M
J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
[TBL] [Abstract][Full Text] [Related]
4. Acidity/Alkalinity of Japanese Encephalitis Virus E Protein Residue 138 Alters Neurovirulence in Mice.
Zheng X; Zheng H; Tong W; Li G; Wang T; Li L; Gao F; Shan T; Yu H; Zhou Y; Qiu Y; Ma Z; Tong G
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158291
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.
Zhao Z; Date T; Li Y; Kato T; Miyamoto M; Yasui K; Wakita T
J Gen Virol; 2005 Aug; 86(Pt 8):2209-2220. PubMed ID: 16033968
[TBL] [Abstract][Full Text] [Related]
6. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
7. A Single Amino Acid Substitution in the M Protein Attenuates Japanese Encephalitis Virus in Mammalian Hosts.
de Wispelaere M; Khou C; Frenkiel MP; Desprès P; Pardigon N
J Virol; 2015 Dec; 90(5):2676-89. PubMed ID: 26656690
[TBL] [Abstract][Full Text] [Related]
8. DC-SIGN Binding Contributed by an Extra N-Linked Glycosylation on Japanese Encephalitis Virus Envelope Protein Reduces the Ability of Viral Brain Invasion.
Liang JJ; Chou MW; Lin YL
Front Cell Infect Microbiol; 2018; 8():239. PubMed ID: 30042931
[TBL] [Abstract][Full Text] [Related]
9. Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability.
Wang X; Li SH; Zhu L; Nian QG; Yuan S; Gao Q; Hu Z; Ye Q; Li XF; Xie DY; Shaw N; Wang J; Walter TS; Huiskonen JT; Fry EE; Qin CF; Stuart DI; Rao Z
Nat Commun; 2017 Apr; 8(1):14. PubMed ID: 28446752
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
11. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain.
Anwar MN; Wang X; Hameed M; Wahaab A; Li C; Sharma M; Pang L; Malik MI; Liu K; Li B; Qiu Y; Wei J; Ma Z
Viruses; 2020 May; 12(5):. PubMed ID: 32429445
[TBL] [Abstract][Full Text] [Related]
13. Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.
Mathenge EGM; Parquet MDC; Funakoshi Y; Houhara S; Wong PF; Ichinose A; Hasebe F; Inoue S; Morita K
J Gen Virol; 2004 Sep; 85(Pt 9):2503-2513. PubMed ID: 15302944
[TBL] [Abstract][Full Text] [Related]
14. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
Lee E; Hall RA; Lobigs M
J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
[TBL] [Abstract][Full Text] [Related]
15. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro.
Chen LK; Lin YL; Liao CL; Lin CG; Huang YL; Yeh CT; Lai SC; Jan JT; Chin C
Virology; 1996 Sep; 223(1):79-88. PubMed ID: 8806542
[TBL] [Abstract][Full Text] [Related]
17. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a serine-to-asparagine substitution at position 123 in the Japanese encephalitis virus E protein.
Yamaguchi Y; Nukui Y; Kotaki A; Sawabe K; Saijo M; Watanabe H; Kurane I; Takasaki T; Tajima S
J Gen Virol; 2013 Jan; 94(Pt 1):90-96. PubMed ID: 23052392
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation at Residue C221 of Japanese Encephalitis Virus NS2A Protein Contributes to Viral Replication Efficiency and Virulence.
Ma X; Xia Q; Liu K; Wu Z; Li C; Xiao C; Dong N; Hameed M; Anwar MN; Li Z; Shao D; Li B; Qiu Y; Wei J; Ma Z
J Virol; 2023 Jun; 97(6):e0038223. PubMed ID: 37289075
[TBL] [Abstract][Full Text] [Related]
20. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Gromowski GD; Firestone CY; Whitehead SS
J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
